APR has successfully accomplished the certification of Nexodyn AcidOxidizing (AOS)™ as Medical Device Class III according to the European regulation 23 October 2015
TGA Approves AKYNZEO® (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) 20 May 2015
Cerbios has been rewarded at Swiss Venture Club Prix 2015 based on its continued Innovation and Sustainability 19 May 2015
Helsinn Group Signs Exclusive Agreement with Mundipharma for Distribution and Licence of Anamorelin in China, Hong Kong and Macao 27 March 2015
Helsinn Group signs exclusive agreements with Mundipharma for distribution and licence of anamorelin in Brazil and across key markets in the Middle East and North Africa 11 February 2015
Helsinn Group signs exclusive agreement with Mundipharma for distribution and licensing of Netupitant/Palonosetron (nepa) in Brazil 10 February 2015
Helsinn and Zealand announce the advance of elsiglutide into Phase IIB development for the prevention of chemotherapyinduced diarrhea 6 February 2015
Linkedin